On June 11, 2025, Onconetix, Inc. announced a reverse stock split at a ratio of 1-for-85, reducing its outstanding shares from approximately 44.4 million to about 521,863. This adjustment will take effect on June 13, 2025, and the company issued a promissory note for $147,058.82 on June 5, 2025.